Skip to main content

Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder

Clinical Research in Cardiology volume 104, pages 530–533 (2015)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, Sheiban I, Saliba Z, Santoro T, Pelissero G, Carminati M, Frigiola A (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7(3):377–385. doi:10.4244/EIJV7I3A63

    Article  PubMed  Google Scholar 

  2. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr (2009) Analysis of the US Food and Drug Administration Manufacturer and user facility device experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137(6):1334–1341. doi:10.1016/j.jtcvs.2009.02.032

    Article  PubMed Central  PubMed  Google Scholar 

  3. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J (2005) Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 45(8):1213–1218. doi:10.1016/j.jacc.2004.12.072

    Article  PubMed  Google Scholar 

  4. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31(23):2915–2957. doi:10.1093/eurheartj/ehq249

    Article  PubMed  Google Scholar 

  5. Kotowycz MA, Therrien J, Ionescu-Ittu R, Owens CG, Pilote L, Martucci G, Tchervenkov C, Marelli AJ (2013) Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv 6(5):497–503. doi:10.1016/j.jcin.2012.12.126

    Article  PubMed  Google Scholar 

  6. Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B (2013) Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovas Interv 82:1123–1138. doi:10.1002/ccd.24875

    Article  Google Scholar 

  7. Roberts WT, Parmar J, Rajathurai T (2013) Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement. Catheter Cardiovasc Interv 82(4):E592–E594. doi:10.1002/ccd.24755

    PubMed  Google Scholar 

  8. Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, Carrel T, Comas JV, Corno AF, Daenen W, Di Carlo D, Ebels T, Fragata J, Hamilton L, Hraska V, Jacobs J, Lazarov S, Mavroudis C, Metras D, Rubay J, Schreiber C, Stellin G (2010) Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg 37(6):1285–1290. doi:10.1016/j.ejcts.2009.12.021

    Article  PubMed  Google Scholar 

  9. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63(4):496–502. doi:10.1002/ccd.20211

    Article  PubMed  Google Scholar 

  10. Amplatzer septal occluder delivery system - instructions for Use, St. Jude Medical (2014) http://manuals.sjm.com/Search-Form?re=North-America&cc=US&ln=all&fam=db52be0a-e057-428d-9897-67e1e67f542e&cat=71260c89-7cb8-475d-950b-0262191e7526&seg=dd28d64f-7d0b-4660-aa2c-da987bb7894c&ipp=10. Accessed January 25, 2015

  11. Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J, Vincent R, Martin G, Committee AIS (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6(5):433–442. doi:10.1016/j.jcin.2013.02.005

    Article  PubMed  Google Scholar 

  12. El-Said HG, Moore JW (2009) Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 73(7):925–930. doi:10.1002/ccd.21931

    Article  PubMed  Google Scholar 

  13. Schubert S, Kainz S, Peters B, Berger F, Ewert P (2012) Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clinical Res Cardiol 101(9):691–700. doi:10.1007/s00392-012-0445-1

    Article  Google Scholar 

  14. Javois AJ, Rome JJ, Jones TK, Zahn EM, Fleishman CE, Pignatelli RH, Latson LA, Gore HCASG (2014) Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect. JACC Cardiovasc Interv 7(8):905–912. doi:10.1016/j.jcin.2014.01.169

    Article  PubMed  Google Scholar 

  15. Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL, Jux C (2006) BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 114(18):1962–1967. doi:10.1161/CIRCULATIONAHA.106.664672

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank S. Ullrich, Institute of Radiology, Triemli Hospital Zurich, Switzerland for providing the CT image shown in Fig. 1b, and F. Osann for expert patient care in the emergency room.

Integrity of research and reporting

The patient was consented to publish this report. The authors declare that they have no conflict of interest.

Author information

Affiliations

  1. Department of Medicine, Limmattal Hospital, Urdorferstrasse 100, 8952, Schlieren, Switzerland

    Thomas Herren & Michael Schwanda

  2. Department of Cardiac Surgery, Triemli Hospital, Birmensdorferstrasse 497, 8063, Zurich, Switzerland

    Michele Genoni

  3. Department of Cardiology, Triemli Hospital, Birmensdorferstrasse 497, 8063, Zurich, Switzerland

    Franz R. Eberli

Authors
  1. Thomas Herren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Schwanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michele Genoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Franz R. Eberli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Herren.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 72 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Herren, T., Schwanda, M., Genoni, M. et al. Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder. Clin Res Cardiol 104, 530–533 (2015). https://doi.org/10.1007/s00392-015-0829-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-015-0829-0

Keywords

  • Pericardial Effusion
  • Cardiac Tamponade
  • Left Atrial Appendage
  • Transcatheter Closure
  • Cardiac Perforation